These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils. Abernathy LM; Fountain MD; Rothstein SE; David JM; Yunker CK; Rakowski J; Lonardo F; Joiner MC; Hillman GG J Thorac Oncol; 2015 Dec; 10(12):1703-12. PubMed ID: 26709479 [TBL] [Abstract][Full Text] [Related]
6. Radiosensitization of prostate cancer by soy isoflavones. Raffoul JJ; Sarkar FH; Hillman GG Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535 [TBL] [Abstract][Full Text] [Related]
7. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503 [TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Hillman GG; Singh-Gupta V; Runyan L; Yunker CK; Rakowski JT; Sarkar FH; Miller S; Gadgeel SM; Sethi S; Joiner MC; Konski AA Radiother Oncol; 2011 Nov; 101(2):329-36. PubMed ID: 22079530 [TBL] [Abstract][Full Text] [Related]
9. Soy isoflavones sensitize cancer cells to radiotherapy. Hillman GG; Singh-Gupta V Free Radic Biol Med; 2011 Jul; 51(2):289-98. PubMed ID: 21605661 [TBL] [Abstract][Full Text] [Related]
10. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy. Sahin I; Bilir B; Ali S; Sahin K; Kucuk O Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972 [TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones and prostate cancer: a review of molecular mechanisms. Mahmoud AM; Yang W; Bosland MC J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791 [TBL] [Abstract][Full Text] [Related]
12. Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury. Fountain MD; McLellan LA; Smith NL; Loughery BF; Rakowski JT; Tse HY; Hillman GG Int J Radiat Biol; 2020 Feb; 96(2):245-256. PubMed ID: 31633433 [No Abstract] [Full Text] [Related]
13. Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives. Uifălean A; Schneider S; Ionescu C; Lalk M; Iuga CA Molecules; 2015 Dec; 21(1):E13. PubMed ID: 26703550 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337 [TBL] [Abstract][Full Text] [Related]
16. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975 [TBL] [Abstract][Full Text] [Related]
17. Soy isoflavones and cognitive function. Lee YB; Lee HJ; Sohn HS J Nutr Biochem; 2005 Nov; 16(11):641-9. PubMed ID: 16169201 [TBL] [Abstract][Full Text] [Related]
18. Rodent Models Assessing Mammary Tumor Prevention by Soy or Soy Isoflavones. Moorehead RA Genes (Basel); 2019 Jul; 10(8):. PubMed ID: 31357528 [TBL] [Abstract][Full Text] [Related]
19. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. Setchell KD; Brown NM; Lydeking-Olsen E J Nutr; 2002 Dec; 132(12):3577-84. PubMed ID: 12468591 [TBL] [Abstract][Full Text] [Related]